Literature DB >> 30326507

Antiphospholipid Syndrome Following Pembrolizumab Treatment of Stage IIIB Unresectable Melanoma.

Adrien Sanchez1, Henri Montaudie1,2, Pierre Bory3, Xavier Belgodere3, Thierry Passeron1,2, Jean Philippe Lacour1, Alexandra Picard1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30326507     DOI: 10.1001/jamadermatol.2018.2770

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  4 in total

1.  Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders.

Authors:  Maria Caputo; Elisabetta Zucchi; Ilaria Martinelli; Giulia Gianferrari; Cecilia Simonini; Amedeo Amedei; Elena Niccolai; Cinzia Gellera; Viviana Pensato; Jessica Mandrioli
Journal:  Neurol Sci       Date:  2021-10-19       Impact factor: 3.830

2.  Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study.

Authors:  José A Gómez-Puerta; David Lobo-Prat; Carolina Perez-García; Andrés Ponce; Beatriz Frade-Sosa; Ana Milena Millán Arciniegas; Fabiola Ojeda; Virginia Ruiz-Esquide; Hector Corominas
Journal:  Front Med (Lausanne)       Date:  2022-06-15

3.  Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis.

Authors:  Andrés Ponce; Beatriz Frade-Sosa; Juan C Sarmiento-Monroy; Nuria Sapena; Julio Ramírez; Ana Belén Azuaga; Rosa Morlà; Virginia Ruiz-Esquide; Juan D Cañete; Raimon Sanmartí; José A Gómez-Puerta
Journal:  Diagnostics (Basel)       Date:  2022-08-13

4.  Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors.

Authors:  Noha Abdel-Wahab; Jean H Tayar; Faisal Fa'ak; Gaurav Sharma; Maria A Lopez-Olivo; Abdelrahman Yousif; Tasneam Shagroni; Sami Al-Hawamdeh; Cristhiam M Rojas-Hernandez; Maria E Suarez-Almazor
Journal:  Blood Adv       Date:  2020-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.